Evidence map›Paper›PMID 40559891›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Immunocompatible Elastomer With Enhanced Fibrous Capsule-Resistance and Elasticity by Water-Induced Surface Phase Reconfiguration.

Xianchi Zhou, Wenzhong Cao, Weifeng Liu, Wenbin Dai, Zihao Zhu, Fan Jia, Haijie Han, Ke Yao, Youxiang Wang, Jian Ji and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xianchi ZhouState Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 311202, P. R. China.
Wenzhong CaoMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
Weifeng LiuDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.
Wenbin DaiMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
Zihao ZhuMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
Fan JiaKey Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, P. R. China.
Haijie HanEye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, Zhejiang, 310009, China.
Ke YaoEye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, Zhejiang, 310009, China.
Youxiang WangMOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
Jian JiState Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 311202, P. R. China.
Peng ZhangState Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 311202, P. R. China.

Funding

National Key Research and Development Program of China 2022YFB3807300National Natural Science Foundation of China 22175152State Key Laboratory of Transvascular Implantation Devices 012024019Transvascular Implantation Devices Research Institute China (TIDRIC) KY012024009Zhejiang Provincial Natural Science Foundation of China LR25E030001
6 · The paper itself

Abstract

Integrating surface and bulk heterogeneity enables synergistic optimization of implantable biomaterials, harmonizing surface-tissue interactions with the mechanical integrity of the bulk. However, achieving this heterogeneity within a single material remains a significant challenge. Here, a strategy to engineer spontaneously generated heterogeneous surface and bulk structures within a material is introduced. The resulting material is termed phase-separation and underwater reconfiguration-enhanced (PURE) elastomers. PURE elastomers integrate the high elasticity of the bulk with superior immunocompatibility at the surface. By de novo designing the immunomodulatory and alkyl acrylate monomer structures, this is regulated that the copolymer's spatial configurations, ultimately influencing its condensed structure. Tuning the alkyl side chain length facilitates the formation of a distinctive phase-separation pattern in elastomers that accommodates large deformations, resulting in excellent toughness and low hysteresis. Moreover, this phase structure supports a water-induced surface phase reconfiguration, aligning with in vivo applications. This reconfiguration enriches immunomodulatory groups at the material surface, significantly enhancing immunocompatibility. Consequently, these elastomers exhibit extremely low fibrotic capsule formation for up to one year in mice and two months in non-human primates. This findings introduce a class of durable, fibrosis-resistant materials and establish a new strategy for designing heterogeneous polymeric elastomers with broad biomedical applicability.

Indexed as

Biocompatible MaterialsElastomersWaterAnimalsElasticityMaterials TestingMiceSurface PropertiesBiocompatible MaterialsElastomersWaterforeign body responseimmunocompatible elastomerimplant, phase reconfigurationsurface‐bulk heterogeneity

Identifiers

PMID40559891
PMCPMC12463074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.